135 related articles for article (PubMed ID: 6735256)
41. Proliferative instability and experimental carcinogenesis at colonic anastomoses.
Roe R; Fermor B; Williamson RC
Gut; 1987 Jul; 28(7):808-15. PubMed ID: 3653750
[TBL] [Abstract][Full Text] [Related]
42. (-)-Epigallocatechin gallate suppresses azoxymethane-induced colonic premalignant lesions in male C57BL/KsJ-db/db mice.
Shimizu M; Shirakami Y; Sakai H; Adachi S; Hata K; Hirose Y; Tsurumi H; Tanaka T; Moriwaki H
Cancer Prev Res (Phila); 2008 Sep; 1(4):298-304. PubMed ID: 19138973
[TBL] [Abstract][Full Text] [Related]
43. Diosgenin, a steroid saponin of Trigonella foenum graecum (Fenugreek), inhibits azoxymethane-induced aberrant crypt foci formation in F344 rats and induces apoptosis in HT-29 human colon cancer cells.
Raju J; Patlolla JM; Swamy MV; Rao CV
Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1392-8. PubMed ID: 15298963
[TBL] [Abstract][Full Text] [Related]
44. Adaptation to jejunoileal bypass promotes experimental colorectal carcinogenesis.
Bristol JB; Wells M; Williamson RC
Br J Surg; 1984 Feb; 71(2):123-6. PubMed ID: 6692105
[TBL] [Abstract][Full Text] [Related]
45. Morphodensitometric analysis of protein kinase C beta(II) expression in rat colon: modulation by diet and relation to in situ cell proliferation and apoptosis.
Davidson LA; Brown RE; Chang WC; Morris JS; Wang N; Carroll RJ; Turner ND; Lupton JR; Chapkin RS
Carcinogenesis; 2000 Aug; 21(8):1513-9. PubMed ID: 10910952
[TBL] [Abstract][Full Text] [Related]
46. Mitogenic effects of both amidated and glycine-extended gastrin-releasing peptide in defunctioned and azoxymethane-treated rat colon in vivo.
Houli N; Loh SW; Giraud AS; Baldwin GS; Shulkes A
Regul Pept; 2006 Mar; 134(1):9-16. PubMed ID: 16297463
[TBL] [Abstract][Full Text] [Related]
47. Inhibitory effects of astaxanthin on azoxymethane-induced colonic preneoplastic lesions in C57/BL/KsJ-db/db mice.
Kochi T; Shimizu M; Sumi T; Kubota M; Shirakami Y; Tanaka T; Moriwaki H
BMC Gastroenterol; 2014 Dec; 14():212. PubMed ID: 25515685
[TBL] [Abstract][Full Text] [Related]
48. Inhibitory effect of caffeic acid esters on azoxymethane-induced biochemical changes and aberrant crypt foci formation in rat colon.
Rao CV; Desai D; Simi B; Kulkarni N; Amin S; Reddy BS
Cancer Res; 1993 Sep; 53(18):4182-8. PubMed ID: 8364913
[TBL] [Abstract][Full Text] [Related]
49. The relationship between intestinal hyperplasia and carcinogenesis.
Williamson RC; Rainey JB
Scand J Gastroenterol Suppl; 1984; 104():57-76. PubMed ID: 6597550
[TBL] [Abstract][Full Text] [Related]
50. Prevalent location of flat dysplastic aberrant crypt foci near lymphoid follicles in the colon of azoxymethane-treated rats.
Paulsen JE; Steffensen IL; Olstørn HB; Alexander J
Anticancer Res; 2006; 26(3A):1803-7. PubMed ID: 16827110
[TBL] [Abstract][Full Text] [Related]
51. Effect of hesperetin, a citrus flavonoid, on bacterial enzymes and carcinogen-induced aberrant crypt foci in colon cancer rats: a dose-dependent study.
Aranganathan S; Selvam JP; Nalini N
J Pharm Pharmacol; 2008 Oct; 60(10):1385-92. PubMed ID: 18812032
[TBL] [Abstract][Full Text] [Related]
52. Strain-specific homeostatic responses during early stages of Azoxymethane-induced colon tumorigenesis in mice.
Guda K; Marino JN; Jung Y; Crary K; Dong M; Rosenberg DW
Int J Oncol; 2007 Oct; 31(4):837-42. PubMed ID: 17786315
[TBL] [Abstract][Full Text] [Related]
53. Colon cancer is induced by a single low dose of azoxymethane in fasted-refed rats.
Caderni G; Bollito E; Tessitore L
Nutr Cancer; 1999; 35(2):137-42. PubMed ID: 10693167
[TBL] [Abstract][Full Text] [Related]
54. Enhancement by vasoactive intestinal peptide of experimental carcinogenesis induced by azoxymethane in rat colon.
Iishi H; Tatsuta M; Baba M; Okuda S; Taniguchi H
Cancer Res; 1987 Sep; 47(18):4890-3. PubMed ID: 3621182
[TBL] [Abstract][Full Text] [Related]
55. Ursodeoxycholic acid and F(6)-D(3) inhibit aberrant crypt proliferation in the rat azoxymethane model of colon cancer: roles of cyclin D1 and E-cadherin.
Wali RK; Khare S; Tretiakova M; Cohen G; Nguyen L; Hart J; Wang J; Wen M; Ramaswamy A; Joseph L; Sitrin M; Brasitus T; Bissonnette M
Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1653-62. PubMed ID: 12496057
[TBL] [Abstract][Full Text] [Related]
56. Ability of aberrant crypt foci characteristics to predict colonic tumor incidence in rats fed cholic acid.
Magnuson BA; Carr I; Bird RP
Cancer Res; 1993 Oct; 53(19):4499-504. PubMed ID: 8402621
[TBL] [Abstract][Full Text] [Related]
57. Identification of mucin-depleted foci in the unsectioned colon of azoxymethane-treated rats: correlation with carcinogenesis.
Caderni G; Femia AP; Giannini A; Favuzza A; Luceri C; Salvadori M; Dolara P
Cancer Res; 2003 May; 63(10):2388-92. PubMed ID: 12750256
[TBL] [Abstract][Full Text] [Related]
58. Promotion of intestinal carcinogenesis by Streptococcus bovis.
Ellmerich S; Schöller M; Duranton B; Gossé F; Galluser M; Klein JP; Raul F
Carcinogenesis; 2000 Apr; 21(4):753-6. PubMed ID: 10753212
[TBL] [Abstract][Full Text] [Related]
59. Scanning electron microscopic study of the collagen networks of the normal mucosa, hyperplastic polyps, tubular adenoma, and adenocarcinoma of the human large intestine.
Furuya Y; Ogata T
Tohoku J Exp Med; 1993 Jan; 169(1):1-19. PubMed ID: 8211966
[TBL] [Abstract][Full Text] [Related]
60. The effect of chilli ingestion on gastrointestinal mucosal proliferation and azoxymethane-induced cancer in the rat.
Kang JY; Alexander B; Barker F; Man WK; Williamson RC
J Gastroenterol Hepatol; 1992; 7(2):194-8. PubMed ID: 1373965
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]